Caprotec Bioanalytics, GmbH: Series B $8.8M

Posted in I - Series B, Q - 1Q08, R - INTERNATIONAL, X - Biomarker, X - Device (Imaging)

Caprotec Bioanalytics (Germany) maker of a mass-spec based compound capture platform for drug development and protein biomarker identification closed a $8.8M Series B financing. Participants include Creathor Venture, IBB Beteiligungsgesellschaft, ERP Startfonds and private investors.

Feb

2008

Genizon Biosciences, Inc.: Series D $31M

Posted in I - Series D, Q - 1Q08, R - INTERNATIONAL, X - Asthma, X - Biomarker, X - Crohn's, X - Schizophrenia

Genizon Biosciences (Canada) is a therapeutic target and biomarker development stage company focused on Crohn’s disease, psoriasis, asthma and schizophrenia has closed a $31M Series D. Participants include BTF B.V.

to top of page...